Luo W, Zheng X, Lin H, Fu L, Long L, Yu D
Chem Sci. 2025; 16(9):4119-4126.
PMID: 39906387
PMC: 11788672.
DOI: 10.1039/d4sc07999j.
Alfei S, Zuccari G
Int J Mol Sci. 2025; 26(2).
PMID: 39859559
PMC: 11766176.
DOI: 10.3390/ijms26020844.
Yasuda K, Berenger F, Amaike K, Ueda A, Nakagomi T, Hamasaki G
iScience. 2025; 28(1):111526.
PMID: 39801837
PMC: 11721219.
DOI: 10.1016/j.isci.2024.111526.
Barbari R, Bruggink V, Hofstetter R, Tupini C, Fagnani S, Baldini E
Antioxidants (Basel). 2024; 13(10).
PMID: 39456450
PMC: 11504387.
DOI: 10.3390/antiox13101196.
Mag P, Nemes-Terenyi M, Jerzsele A, Matyus P
Molecules. 2024; 29(18).
PMID: 39339469
PMC: 11433938.
DOI: 10.3390/molecules29184475.
Design, Synthesis, and Characterization of Novel Cannabidiol-Based Derivatives with Potent Antioxidant Activities.
Peretz E, Musa S
Int J Mol Sci. 2024; 25(17).
PMID: 39273525
PMC: 11395037.
DOI: 10.3390/ijms25179579.
Comprehensive detection and characterization of human druggable pockets through binding site descriptors.
Comajuncosa-Creus A, Jorba G, Barril X, Aloy P
Nat Commun. 2024; 15(1):7917.
PMID: 39256431
PMC: 11387482.
DOI: 10.1038/s41467-024-52146-3.
Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies.
Zuo W, Pang Q, Zhu X, Yang Q, Zhao Q, He G
J Hematol Oncol. 2024; 17(1):81.
PMID: 39232809
PMC: 11375894.
DOI: 10.1186/s13045-024-01601-1.
Multitarget Pharmacology of Sulfur-Nitrogen Heterocycles: Anticancer and Antioxidant Perspectives.
Drakontaeidi A, Papanotas I, Pontiki E
Antioxidants (Basel). 2024; 13(8).
PMID: 39199144
PMC: 11351258.
DOI: 10.3390/antiox13080898.
Medicinal polypharmacology-a scientific glossary of terminology and concepts.
Stefan S, Rafehi M
Front Pharmacol. 2024; 15:1419110.
PMID: 39092220
PMC: 11292611.
DOI: 10.3389/fphar.2024.1419110.
Natural Product-Inspired Dopamine Receptor Ligands.
Dorogan M, Namballa H, Harding W
J Med Chem. 2024; 67(15):12463-12484.
PMID: 39038276
PMC: 11320586.
DOI: 10.1021/acs.jmedchem.4c00537.
Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative Disorders.
Niazi S, Magoola M, Mariam Z
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931409
PMC: 11206655.
DOI: 10.3390/ph17060741.
Systematic Investigation of Dual-Target-Directed Ligands.
Lembo V, Bottegoni G
J Med Chem. 2024; 67(12):10374-10385.
PMID: 38843874
PMC: 11215722.
DOI: 10.1021/acs.jmedchem.4c00838.
Computer-aided pattern scoring - A multitarget dataset-driven workflow to predict ligands of orphan targets.
Stefan K, Namasivayam V, Stefan S
Sci Data. 2024; 11(1):530.
PMID: 38783061
PMC: 11116543.
DOI: 10.1038/s41597-024-03343-8.
Exploring acetaminophen prodrugs and hybrids: a review.
Kouznetsov V
RSC Adv. 2024; 14(14):9691-9715.
PMID: 38525062
PMC: 10958773.
DOI: 10.1039/d4ra00365a.
Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach.
Barbosa D, do Bomfim M, de Oliveira T, da Silva A, Taranto A, Cruz J
Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139784
PMC: 10748024.
DOI: 10.3390/ph16121657.
Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.
Kumar S, Mahajan A, Ambatwar R, Khatik G
Curr Med Chem. 2023; 31(37):6032-6062.
PMID: 37861025
DOI: 10.2174/0109298673264076230921065945.
Cytotoxicity of a new spiro-acridine derivative: modulation of cellular antioxidant state and induction of cell cycle arrest and apoptosis in HCT-116 colorectal carcinoma.
Sousa V, Sousa Duarte S, Silva D, Ferreira R, Olimpio de Moura R, Segundo M
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(3):1901-1913.
PMID: 37676494
DOI: 10.1007/s00210-023-02686-0.
Xanthine-Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases.
Zaluski M, Karcz T, Drabczynska A, Vielmuth C, Olejarz-Maciej A, Gluch-Lutwin M
Biomolecules. 2023; 13(7).
PMID: 37509114
PMC: 10377586.
DOI: 10.3390/biom13071079.
Enhanced Bystander BRET (ebBRET) Biosensors as Biophysical Tools to Map the Signaling Profile of Neuropsychiatric Drugs Targeting GPCRs.
Gaitonde S, Bouvier M
Methods Mol Biol. 2023; 2687:15-30.
PMID: 37464159
DOI: 10.1007/978-1-0716-3307-6_2.